Introduction In the last decade several studies have been performed to evaluate the clinical outcome of one or two stage loaded implants supporting overdentures. Aim Since fresh frozen bone (FFB) has an ever-increasing number of clinical applications and few reports are available on implants inserted into FFB, we performed a retrospective study on fixtures inserted in FFB and bearing overdentures. Methods In the period between December 2003 and December 2006, 17 patients (14 females and 3 males with a median age of about 56 years) were grafted and 60 implants inserted thereafter. A total of 17 overdentures were delivered: 8 in the mandible and 9 in the maxilla. Multiple implant systems were used: 22 Double etched, 7 SLA, 9 Anodic oxidized, and 22 CaPo 4 ceramic-blasted. Implant diameter ranged from 3.25 to 4.3 mm and length from 11.5 to 16.0 mm. Implants were inserted to replace 23 incisors, 9 cuspids, 20 premolars and 8 molars.
INTRODUCTION
Overdentures (ODs) are reliable, non-invasive, low cost devices for replacing missing teeth. Implants can retain ODs in both jaws and they greatly improve the retention and stability of dentures [1, 2] . In the mandible OD design is based on two to four implants placed in the interforaminal region, possibly connected together with a bar [3] . In the maxilla, it is usually recommended that a minimum of four implants joined together with two lateral bars are provided due to the poorer bone quality of the upper jaw [4] .
Clinical trials on implant-retaining ODs report a cumulative survival rate (SVR i.e. total implants still in place at the end of the follow-up) of about 90% at 5 years and a success rate (SCR i.e. good clinical, radiological and aesthetic outcome) of more then 85% [1] [2] [3] [4] . Immediate loading (i.e. placing the final or provisional prosthetic restoration immediately after the surgical procedure) of four implants retaining mandibular Ods [5] is a predictable procedure, which permits successful dental rehabilitation with a shortening of treatment times. Even in a totally edentulous maxilla immediate loading of ODs is a successful procedure [6] .
In recent years, several reports have become available on atrophied edentulous jaws grafted with autologous bone to restore alveolar ridge volume prior to implant insertion [7] [8] [9] [10] . Although autografts are the standard procedure for bone grafting, it is sometimes not possible to collect an adequate amount of bone from other donor sites in the same patient [11] . Moreover, autologous bone grafts have the drawback of requiring secondary surgery for autograft retrieval, with increased operation time, and donor site morbidity. On the other hand, biomaterials are good but expensive, and may extrude at a later date. So, the use of homografts provides a reasonable alternative to meet the need for graft material [11] .
A homograft (or allograft) is a transplant in which transplanted cells, tissues or organs are sourced from a genetically non-identical member of the same species. Bone allograft transplantation has been performed in humans for more than one hundred years and is being used in increasing numbers by orthopedic surgeons [12] .
Many forms of banked bone allograft are available: among them are fresh frozen bone (FFB), freeze dried bone (FDB), and demineralized fresh dried bone (DFDB). Each one of these grafts carries risks and has unique limitations and handling properties. In order to use these materials appropriately, the surgeon must be familiar with the properties of each of them and must feel confident that the bone bank providing the graft is supplying a safe and sterile graft [13] .
Since FFB has an ever-increasing number of clinical applications and no report is available on implants inserted into FFB and bearing ODs we therefore decided to perform a retrospective study.
METHODS

Patients
In the period between December 2003 and December 2006, 81 patients (52 females and 29 males) with a median age of 52 years were operated on at the Civil Hospital, Castelfranco Veneto, Italy. Among them, 17 patients (14 females and 3 males) with a median age of 56 years were grafted with FFB and then implants were inserted. A total of 17 ODs were delivered: 8 in the mandible and 9 in the maxilla. Informed written consent approved by the local Ethics Committee was obtained from patients to use their data for research purpose. The mean implant follow-up was 26 months.
Homologue FFBs were inserted in patients' jaws under general anesthesia. All patients have atrophic jaws due to lost teeth. Usually the mean post-grafting period was 6 months before implant surgery and the final prosthetic restoration was delivered after an additional 6 months.
Subjects were screened according to the following inclusion criteria for implant placement: controlled oral hygiene, the absence of any lesions in the oral cavity, sufficient residual bone volume (i.e. autologous plus FFB graft) to receive implants of 3.25 mm in diameter and 11.5 mm in length; in addition, the patients had to agree to participate in a post-operative check-up program.
Exclusion criteria were as follows: a high degree of bruxism, smoking more than 20 cigarettes/day and excessive consumption of alcohol, localized radiation therapy of the oral cavity, antitumor chemotherapy, liver, blood and kidney diseases, immunosupressed patients, patients taking corticosteroids, pregnant women, inflammatory and autoimmune diseases of the oral cavity, poor oral hygiene.
Graft material
The FFB -obtained from the Veneto Tissue Bank in Treviso (Italy) -is a mineralized, non-irradiated, only disinfected and frozen homologous bone (Regione Veneto, Law n. 3948, 15 December 2000). The bone harvesting is obtained from the anterior and posterior iliac crest, in the first 12 hours after donor death. The bone is then disinfected, for at least 72 hours at -4°C, in a polychemotherapeutic solution of vancomycine, polymyxine, glazidine and lincomycine, following that the sample is irrigated with a sterile saline solution. The sample is then subdivided into cortico-medullary blocks, packed in double sterile casing and frozen at -80°C.
The requirements for homologous bone donors are more stringent with respect to those of organ donors. The presence of risk factors such as contagious disease, neoplasm, rheumatical and/or degenerative disease and sepsis necessarily disqualifies the donor. In order to detect infectious agents, the following tests are performed on donor blood samples taken within 8 hours of death: anti-HIV-I/II Ab, anti-HCV Ab, HbsAg, anti-HBc Ab, antiHBs Ab, anti-HTLV-I/II Ab, anti-Ag Treponemal Ab, anti-CMV IgG Ab, anti-CMV IgM Ab, anti-Toxoplasma IgG Ab, anti-Toxoplasma IgM Ab. A culture is also performed to detect aerobic and anaerobic bacteria, mycobacteria and mycotical agents. As a further safety method, a serological follow-up is conducted using Polymerase Chain Reaction techniques to detect any viral RNA or DNA of HIV, HCV and HBV. This method reduces the "diagnostic window period" to 7 days for HIV, HCV and HBV.
Grafting procedure and outcome
Data regarding grafting procedure and FFB outcome were recently published [14] .
Data collection
Before surgery, radiographic examinations were done with the use of orthopantomograph and CT scans.
In each patient, peri-implant crestal bone levels were evaluated by the calibrated examination of ortopantomograph x-rays (Ortoralix SD, Gendex, Milano, Italia). Measurements were recorded before surgery, after surgery and at the end of the follow-up period. The measurements were carried out mesially and distally to each implant, calculating the distance between the implant abutment junction and the bone crestal level. The bone level recorded just after the surgical insertion of the implant was the reference point for the following measurements. The measurement was rounded off to the nearest 0.1 mm. A Peak scale loupe (The GWJ Company, Hacienda Heights, CA, USA) with a magnifying factor of seven times and a scale graduated in 0.1 mm was used.
Peri-implant probing was not performed since controversy still exists regarding the correlation between probing depth and implant success rates [15, 16] .
The implant success rate (SCR) was evaluated according to the following criteria: absence of persisting pain or dysesthesia; absence of peri-implant infection with suppuration; absence of mobility; and absence of persisting periimplant bone resorption greater than 1,5 mm during the first year of loading and 0,2 mm/years during the following years [17] .
Implants
A total of 60 implants were inserted in 17 patients: 9 (15.0%) and 51 (85.0%) in partially and totally edentulous patients, respectively. Twenty (33.3%) were placed as four implants connected with two bars (FICWTB) in the maxilla to support prosthetic restorations and 40 (66.7%) in the remaining ODs which were retained by 2 implants (n=3 prostheses, all in the mandible), 3 fixtures (n=6 prostheses, 5 in the mandible and one in the maxilla), 5 implants (n=2 prostheses, all in maxilla) and 6 implants (n=1 prosthetic restoration in maxilla). There were 22 Double etched (3i implants, Osseotite, Biomet Inc., US), 7 SLA (Astra implants, Astratech Inc., US), 9 Anodic oxidized, and 22 CaPo 4 Ceramic-blasted (RBM implants, Lifecore Biomedical Inc., US).
Implant diameter and length ranged from 3.25 to 4.3 mm and from 11.5 to 16.0 mm, respectively. Implants were inserted to replace 23 incisors, 9 cuspids, 20 premolars and 8 molars.
Implantological and prosthetic technique
All patients underwent the same surgical protocol. An antimicrobial prophylaxis was administered with 500 mg Amoxycillin twice daily for 5 days starting 1 hour before surgery. Local anesthesia was induced by infiltration with articaine/epinephrine and post-surgical analgesic treatment was performed with 100 mg Nimesulid twice daily for 3 days. Oral hygiene instructions were provided.
After making a crestal incision a mucoperiosteal flap was elevated. Implants were inserted according to the procedures recommended. The implant platform was positioned at the alveolar crest level. Sutures were removed 14 days after surgery. After 24 weeks from implant insertion, the provisional prosthesis was provided and the final restoration was usually delivered within an additional 4 weeks. The number of prosthetic units (i.e. NPU, implant/ crown ratio) was about 0.3. All patients were included in a strict hygiene recall.
A total of 17 ODs were delivered: 8 in the mandible and 9 in the maxilla. In the maxilla there were 5 FICWTB; all the remaining ODs were supported by 2 implants (n=3 prostheses) or 3 implants (n=6 prostheses) or 5 implants (n=2 prostheses) or 6 implants (n=1 prosthetic restoration). Thirty-nine implants were inserted in the maxilla and 21 in the mandible. The antagonist was a complete prosthesis in 12 cases, a mix of natural teeth and prosthesis in 4 cases and natural teeth only in one case. All the antagonists of the mandible were complete prostheses; among the antagonists of the maxilla, 4 were complete prostheses, 3 partial prostheses and 1 was made of natural teeth. Fifteen patients had bimaxillary total edentulism, whereas two were partially edentulous in the antagonist jaw.
Statistical analysis
Since no implants were lost (i.e. SVR = 100%), no or reduced crestal bone resorption was considered an indicator of SCR to evaluate the effect of several host-, implant-, and occlusion-related factors.
The difference between the implant abutment junction and the bone crestal level was defined as the Implant Abutment Junction (IAJ) and calculated at the time of operation and during follow-up. The delta IAJ is the difference between the IAJ at the last check-up and the IAJ recorded just after the operation. Delta IAJ medians were stratified according to the variables of interest. Disease-specific survival curves were calculated according to the product-limit method (Kaplan-Meier algorithm) [18] . Cox regression analysis was then applied to determine the single contribution of covariates on survival rate [19] . Stepwise Cox analysis allowed us to detect the variables most associated with implant' survival and/or success. Tables 1 to 6 report the median delta IAJ according to the studied variables. No implants were lost in the post-operative period (i.e. SVR=100%).
RESULTS
As regards SCR, the Kaplan Meier algorithm demonstrates that no variables are associated with statistically significant differences in the delta IAJ (also comparing ODs vs. FICWTB, Log rank test 1.54; df=1; p=0.2). Cox regression gave the same result (Table 7) . 
DISCUSSION
The identification of guidelines for the long term SVR (i.e. total implants still in place at the end of the follow-up) and SCR (i.e. good clinical, radiological and aesthetic outcome) are the main goals of the recent literature. Several variables can influence the final result, but in general they can be grouped as surgery-, host-, implant-, and occlusion-related factors [20] . The surgery-related factors comprise several variables such as an excess of surgical trauma for instance, thermal injury [21] , bone preparation, drill sharpness and design [22] . Bone quality and quantity are the most important host-related factors [22, 23] , while length [24] and design [25] , surface coating [26] , and diameter [27, 28] are the strongest implant-related factors. Finally, quality and quantity of force [29] and prosthetic design [30] are the variables of interest among the occlusion-related factors. All these variables are a matter of scientific investigation since they may affect the clinical outcome. In general, length (Table 2) , diameter (Table 3 ) and type (Table 4 ) are considered to be relevant fixture-related factors. In the present study none has had a statistically significant impact on the clinical outcome. Previous reports on implants inserted into autologous iliac crest bone graft and supporting fixed restoration have comparable results [7] [8] [9] [10] .
Bone quality, a host-related factor, is believed to be one of the most important predictors of outcome. It is generally accepted that the mandible (especially the interforaminal region) has a better bone quality than the maxilla, and this fact is probably the reason why several reports are available regarding critical occlusal procedure (i.e. immediate loading) of implants inserted into the mandible with a high SVR [5] . Our data has shown that FFB is an effective material for restoring alveolar ridge volume as no implants were lost nor was alveolar bone greatly resorbed.
In a recent report Sjöström et al. [9] performed a longitudinal follow-up study of implant stability in grafted maxillae. A total of 192 implants were placed with a survival rate of 90% at the 3-year follow up. Twelve of the 20 failed implants were lost before loading (early failures), whereas the change in the marginal bone level was 0.3±0.3 mm between baseline (bridge delivery) and the 3-year follow up. This datum indicates a better SCR for implant inserted in autografts compared to those inserted in FFB.
Among the occlusal-related factors, FICWTB were analyzed separately from other types of ODs (i.e. supported by 2, 3, 5 or 6 implants) but no statistically differences were detected. This is in agreement with other reports where different numbers of implants were successfully used to bear ODs [1] [2] [3] [4] [5] [6] .
CONCLUSION
FFB is a reliable grafting material for the insertion of implants retaining ODs. Fixtures inserted in FFB had a high survival and success rate similar to those reported in previous studies on non-grafted jaws. Implants inserted in FFB are successful devices for oral rehabilitation. 
KRATAK SADRŽAJ
Uvod U po sled njoj de ce ni ji ne ko li ko stu di ja je is pi ti va lo kli nič ki uspeh jed no ste pe no ili dvo ste pe no op te re će nih im plan ta ta supra den tal nim pro te za ma. Cilj ra da Ka ko sve ža za mr znu ta kost (SZK) ima sve ve ći po ten ci jal u kli nič koj pri me ni, a tek ne ko li ko stu di ja je ura đe no na im planta ti ma ugra đe nim u SZK, ura di li smo ovu re tro spek tiv nu stu di ju na im plan ta ti ma ugra đe nim u SZK i op te re će nim su pra den talnim pro te za ma. Me to de ra da Od de cem bra 2003. do de cem bra 2006. go di ne kod 17 pa ci je na ta (14 že na) pro seč ne sta ro sti od 56 go di na ugrađe ni su graf to vi i 60 im plan ta ta na kon to ga. Ukup no je ugra đe no 17 su pra den tal nih pro te za: osam u man di bu li i de vet u mak sili. Ugra đe na su 22 im plan ta ta sa dvo stru kim na gri za njem, se dam SLA, de vet anod no ok si di sa nih i 22 Ca PO 4 ke ra mič ka. Preč nik im plan ta ta je bio 3,25-4,3 mm, dok je du ži na bi la 11,5-16,0 mm. Im plan ta ti su za me ni li 23 se ku ti ća, de vet oč nja ka, 20 pre mo la ra i osam mo la ra. Re zul ta ti Ni je dan im plan tat ni je bio ne u spe šan i ni je za be le že na sta ti stič ki zna čaj na raz li ka iz me đu po sma tra nih pa ra me ta ra. Kaplan-Ma je rov (Ka plan-Me i er) al go ri tam i Kok so va (Cox) re gre si ja ni su po ka za li zna čaj ne raz li ke iz me đu po sma tra nih pa ra me ta ra u po gle du sto pe uspe šno sti. Za klju čak Im plan ta ti ugra đe ni u SZK i op te re će ni su pra den tal nim pro te za ma ima ju vi so ke sto pe uspe šno sti i pre ži vlja va nja, slič-ne im plan ta ti ma u ko sti bez graf ta. SZK je po uz dan ma te ri jal za aug men ta ci ju al ve o lar nog gre be na. Ni je utvr đe na raz li ka iz me đu par ci jal nih pro te za na dva im plan ta ta ili vi še njih.
Ključ ne re či: ili jač na kost; alo graft; ho mo graft; su pra den tal ne pro te ze; aug men ta ci ja gre be na
UVOD
Su pra den tal ne pro te ze (SP) su po u zda ne, ne in va ziv ne i jef ti ne na dok na de ko ji ma se za me nju ju zu bi ko ji ne do sta ju. Mo gu biti pod u pr te im plan ta ti ma u obe vi li ce, a zna čaj no po ve ća va ju re ten ci ju i sta bil nost pro te za [1, 2] . U man di bu li je di zajn SP za sno van na dva do če ti ri im plan ta ta u in ter fo ra mi nal noj regi ji, ko ji mo gu bi ti po ve za ni spoj ni com [3] . U mak si li se obič-no pre po ru ču je spa ja nje naj ma nje če ti ri im plan ta ta sa dve late ral ne spoj ni ce zbog sla bi jeg kva li te ta ko sti u gor njoj vi li ci [4] . Kli nič ke stu di je na SP no še nim im plan ta ti ma pri ka zu ju kumu la tiv nu sto pu pre ži vlja va nja (SVR, tj. uku pan broj im plan ta ta in si tu na kra ju pe ri o da pra će nja) od oko 90% po sle pet go di na i sto pu uspe šno sti (SCR, tj. do bar kli nič ki, ra di o lo ški i estet ski is hod) od pre ko 85% [1] [2] [3] [4] . Ime di jat no op te re će nje (po sta vljanje ko nač ne ili pri vre me ne pro te tič ke na dok na de ne po sred no na kon hi rur ške pro ce du re) če ti ri im plan ta ta ko ja no se man dibu lar nu SP je pred vi dljiv po stu pak ko ji omo gu ća va uspe šnu reha bi li ta ci ju sa skra ći va njem kli nič kog rad nog vre me na [5] . Čak i kod pa ci je na ta ko ji u gor njoj vi li ci ne ma ju zu ba ovo op te re će-nje SP se sma tra uspe šnom pro ce du rom [6] .
Po sled njih go di na iz ve de no je ne ko li ko stu di ja na atro fi ranim be zu bim vi li ca ma s auto log nim ko šta nim graf to vi ma koji ma je na dok na đen vo lu men al ve o lar nog gre be na pre ugradnje im plan ta ta [7] [8] [9] [10] . Iako su auto graf to vi stan dar dan po stu pak za ko šta nu aug men ta ci ju, po ne kad ni je mo gu će uze ti do volj nu ko li či nu ko sti sa dru gih do nor skih me sta kod jed nog istog paci jen ta [11] . Osim to ga, auto log ni ko šta ni graft ima ma nu jer zah te va se kun dar nu hi rur šku in ter ven ci ju na do nor skom mestu, što pro du ža va rad no vre me i mor bi di tet do nor skog me sta. S dru ge stra ne, bi o ma te ri ja li su do bri, ali sku pi, te mo gu bi ti od ba če ni u ka sni joj fa zi. Za to upo tre ba ho mo graf to va pred stavlja do bru al ter na ti vu, ko jom se za do vo lja va ju zah te vi ma te rija la za graf to ve [11] .
Ho mo graft (ili alo graft) je tran splan tat u ko jem pre sa đe-ne će li je, pre sa đe na tki va i or ga ni po ti ču od ge net ski raz li či tih čla no va iste vr ste. Tran splan ta ci ja ko šta nog alo graf ta se oba vlja na lju di ma već vi še od sto ti nu go di na, naj če šće pri li kom or toped skih in ter ven ci ja [12] . Do stup ni su raz li či ti ob li ci ko šta nih alo graf to va: sve ža za mr znu ta kost (SZK), za mr znu ta su va kost (ZSK) i de mi ne ra li zo va na sve ža su va kost (DSSK). Sva ki od njih no si od re đe ne ri zi ke i ima je din stve ne ma ne i oso bi ne ru ko vanja. Da bi se ovi ma te ri ja li pra vil no upo tre bi li, hi rurg mo ra pozna va ti oso bi ne sva ko ga od njih i bi ti si gu ran da ban ka graf tova obez be đu je bez bed ne i ste ril ne graf to ve [13] .
Bu du ći da SZK ima sve vi še kli nič kih pri me na, a ne ma dostup nih stu di ja ko je su opi sa le im plan ta te ugra đe ne u SZK i op te re će ne SP, od lu či li smo da ura di mo re tro spek ti vu stu diju upra vo o to me.
METODE RADA Pacijenti
Od de cem bra 2003. do de cem bra 2006. go di ne ukup no 81 paci jent (52 žen skog i 29 mu škog po la) pro seč ne sta ro sti od 52 go di ne ope ri san je u Ci vil noj bol ni ci u Ka stel fran ku Ve ne tu, u Ita li ji. Kod 17 ovih pa ci je na ta (14 že na) pro seč ne sta ro sti od 56 go di na ugra đe ni su graf to vi SZK i im plan ta ti. Ukup no 17 SP je ugra đe no po sle to ga: osam u do njoj i de vet u gor njoj vi li ci. Od sva kog pa ci jen ta je do bi jen pot pi sa ni pri sta nak na in ter ven ci ju, a stu di ju je odo brio Etič ki ko mi tet usta no ve. Pro seč no vre me pra će nja im plan ta ta bilo je 26 me se ci.
Ho mo log ni SZK graf to vi su ugra đe ni u op štoj ane ste zi ji. Svi pa ci jen ti su ima li atro fič ne vi li ce zbog ne do stat ka zu ba. Obič-no je pro se čan tzv. post graf ting pe riod tra jao šest me se ci pre im plant ne hi rur gi je i do dat nih šest me se ci pre ko nač ne pro tetič ke re kon struk ci je.
Is pi ta ni ci su oda bra ni pre ma sle de ćim kri te ri ju mi ma: kontro li sa na oral na hi gi je na, od su stvo le zi ja u usnoj du plji, do voljan vo lu men ko sti (auto log ni plus SZK graft) -za im plan ta te 3,25 mm u preč ni ku i 11,5 mm du ži ne, i pri sta nak pa ci jen ta da uče stvu je u pro gra mu nad gle da nja po sle ope ra ci je. Kri te ri ju mi za is klju či va nje iz stu di je bi li su: iz ra žen bruk si zam, pu še nje više od 20 ci ga re ta dnev no, ne u me re no kon zu mi ra nje al ko ho la, lo ka li zo va na ra di o te ra pi ja usne du plje, he mi o te ra pi ja kod tumo ra, obo lje nja je tre, kr vi i bu bre ga, imu no su pre si ja, kor ti koste ro id na te ra pi ja, trud no ća, za pa ljenj ske i auto i mu ne bo le sti usne du plje i lo ša oral na hi gi je na.
Materijal za graft
SZK iz tkiv ne ban ke "Ve ne to" u Tre vi zu (Ita li ja) je mi ne ra li zova ni, ne zra če ni, dez in fi ko va ni, smr znu ti pre pa rat ho mo log ne ko sti. Kost je do bi je na iz pred nje i zad nje ili jač ne ko sti to kom pr vih 12 sa ti od smr ti da va o ca. Kost je za tim dez in fi ko va na najma nje 72 sa ta na tem pe ra tu ri od -4°C u po li he mo te ra pij skom ras tvo ru van ko mi ci na, po li mik si na, gla zi di na i lin ko mi ci na, posle če ga je is pi ra na ste ril nim fi zi o lo škim ras tvo rom. Uzo rak kosti je za tim po de ljen na kor ti ko me du lar ne blo ko ve, pa ko va ne u dvo stru ko ste ri li sa nim pa ko va nji ma, ko ji su smr znu ti na -80°C.
Zah te vi za da va o ce ho mo log ne ko sti su oštri ji ne go za da va oce or ga na. Fak to ri ri zi ka za in fek tiv no obo lje nje, neo pla zmu, reu ma to id no, od no sno de ge ne ra tiv no obo lje nje i sep su auto matski dis kva li fi ku ju da va o ca. Da bi se ot kri li in fek tiv ni agen si, izve de ni su sle de ći te sto vi na tki vi ma da va o ca u ro ku od osam sati od tre nut ka smr ti: an ti-HIV-I/II Ab, an ti-HCV Ab, an ti-Hbs Ag, an ti-HBc Ab, an ti-HBs Ab, an ti-HTLV-I/II Ab, an ti-Ag Trepo ne ma Ab, an ti-CMV IgG Ab, an ti-CMV IgM Ab, an ti-To xopla sma IgG Ab, an ti-To xo pla sma IgM Ab. Za se ja va nje je ta kođe ura đe no, ka ko bi se ot kri le aerob ne i ana e rob ne bak te ri je, mi ko bak te ri je i mi ko tič ni agen si. Kao još jed na me ra pre venci je, se ro lo ško is pi ti va nje je oba vlje no pri me nom PCR teh ni ke, da bi se ot kri li RNK i DNK HIV, HCV i HBV vi ru si. Ovaj metod sma nju je tzv. pe riod di jag no stič kog pro zo ra na se dam dana za HIV, HCV i HBV.
Grafting procedura i ishod
Po da ci o ovoj pro ce du ri i is ho du su ne dav no ob ja vlje ni [14] .
Prikupljanje podataka
Pre hi rur ške in ter ven ci je ura đe ni su OPT i CT. Kod sva kog paci jen ta ni vo pe ri im plant ne ko sti je pro ce njen na osno vu ka li brisa nih OPT sni ma ka (Or to ra lix SD, Gen dex, Mi lan, Italy). Me renja su ura đe na pre i po sle ope ra ci je i na kra ju pe ri o da pra će nja. Me re nja su ra đe na me zi jal no i dis tal no od sva kog im plan ta ta, pri če mu je iz ra ču na ta uda lje nost iz me đu im plan ta ta i ni voa košta nog gre be na. Ni vo ko sti ne po sred no na kon hi rur ške ugradnje im plan ta ta je slu žio kao re fe rent na vred nost za ka sni ja mere nja. Me re nje je za o kru ži va no na naj bli ži 0,1 mm. Ko ri šće na je uve li ča va ju ća lu pa (The GWJ Com pany, Ha ci en da He ights, CA, USA) sa uve li ča njem od se dam pu ta i gra du i sa nom ska lom od 0,1 mm. Pe ri im plant no son di ra nje ni je ra đe no zbog kon troverz nih sta vo va o even tu al noj ko re la ci ji iz me đu du bi ne son dira nja i sto pe uspe šno sti im plan ta ta [15, 16] .
Sto pa uspe šno sti im plan ta ta (SCR) je pro ce nje na na osnovu sle de ćih kri te ri ju ma: iz o sta nak bo la ili pa re ste zi je, pe ri implan ti ti sa sa su pu ra ci jom, mo bil no sti, per zi stent ne re sorp ci je ko sti oko im plan ta ta ko ja je ve ća od 1,5 mm to kom pr ve go dine po sle op te re će nja, od no sno 0,2 mm go di šnje to kom na rednih go di na [17] .
Implantati
Ukup no 60 im plan ta ta je ugra đe no kod 17 pa ci je na ta: de vet (15,0%) kod kre zu bih i 51 (85,0%) kod be zu bih pa ci je na ta. Dvade set (33,3%) je ura đe no kao si stem od če ti ri im plan ta ta po veza na sa dve spoj ni ce (FICWTB) u gor njoj vi li ci i 40 (66,7%) kao si stem od dva im plan ta ta (tri pro te ze u do njoj vi li ci), tri fik sna si ste ma (pet pro te za u do njoj i jed na u gor njoj vi li ci), pet implan ta ta (dve pro te ze u gor njoj vi li ci) i šest im plan ta ta (jed na pro te za u gor njoj vi li ci). Ugra đe na su ukup no 22 im plan ta ta sa dvo stru kim na gri za njem (3i im plan ta ti, Os se o ti te, Bi o met Inc., USA), se dam SLA (Astra im plants, Astra tech Inc., USA), de vet anod no ok si di sa nih i 22 Ca PO 4 ke ra mič ka (RBM im plants, Life co re Bi o me di cal Inc., USA).
Preč nik im plan ta ta je bio 3,25-4,3 mm, dok je du ži na bi la 11,5-16,0 mm. Im plan ta ti su za me ni li 23 se ku ti ća, de vet oč njaka, 20 pre mo la ra i osam mo la ra.
Implantološka i protetična tehnika
Kod svih pa ci je na ta je pri me njen isto ve tan hi rur ški pro to kol. An ti bi ot ska pro fi lak sa je pod ra zu me va la 500 mg amok si ci lina dva pu ta dnev no to kom pet da na, po čev od pr vog sa ta pre ope ra ci je. Lo kal na ane ste zi ja je po stig nu ta in fil tra ci jom ar ti kai na i epi ne fri na, a anal ge tič ki tret man po sle ope ra ci je je podra zu me vao pri me nu 100 mg ni me su li da dva pu ta dnev no tokom tri da na. Pa ci jent je po sa ve to van o to me ka ko da odr ža-va oral nu hi gi je nu.
Po sle in ci zi je u pre de lu gre be na, odig nut je mu ko pe ri o stal ni re žanj. Im plan ta ti su ugra đe ni u skla du s pre po ru če nom proce du rom za sva ki tip. Plat for ma im plan ta ta je po zi ci o ni ra na u ni vou al ve o lar nog gre be na. Su tu re su uklo nje ne 14 da na po sle hi rur ške in ter ven ci je. Po sle 24 ne de lje od ugrad nje im plan ta ta, pri vre me ne pro te tič ke na dok na de su ura đe ne, a ko nač ne od lože ne za do dat ne če ti ri ne de lje. Broj pro te tič kih je di ni ca (NPU, od nos im plan ta ta i kru ne) je bio oko 0,3. Svi pa ci jen ti su uključe ni u pro gram nad gle da nja po sle ope ra ci je.
Ukup no je ugra đe no 17 SP: osam u do njoj i de vet u gor njoj vi li ci. U gor njoj vi li ci je bi lo pet FICWTB; pre o sta le SP su bile pod u pr te sa dva im plan ta ta (tri pro te ze), tri im plan ta ta (šest pro te za), pet im plan ta ta (dve pro te ze) ili šest im plan ta ta (jed na pro te za). U gor nju vi li cu ugra đe no je 39 im plan ta ta, a u do nju
